LADENBURG THALMANN FINANCIAL SERVICES INC. - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 136 filers reported holding IMMUNOMEDICS INC in Q1 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q4 2019$65,000
+103.1%
3,100
+28.5%
0.00%
Q3 2019$32,000
+23.1%
2,412
+26.0%
0.00%
Q2 2019$26,000
-25.7%
1,914
+1.0%
0.00%
Q1 2019$35,0001,895
+5473.5%
0.00%
Q4 2018$0
-100.0%
34
-98.3%
0.00%
Q3 2018$42,000
-37.3%
2,000
-56.2%
0.00%
-100.0%
Q2 2018$67,0000.0%4,5710.0%0.00%0.0%
Q1 2018$67,000
+3250.0%
4,571
+3677.7%
0.00%
Q4 2017$2,000
+100.0%
121
-39.5%
0.00%
Q4 2016$1,0000.0%2000.0%0.00%
Q3 2016$1,0002000.0%0.00%
Q2 2016$0
-100.0%
200
-93.3%
0.00%
Q4 2014$14,0003,0000.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,711,067$2,943,0001.70%
J.P. Turner & Co Capital Mnagement, LLC 248,625$428,0000.44%
Orbimed Advisors 3,323,000$5,716,0000.06%
BALYASNY ASSET MANAGEMENT L.P. 2,004,078$3,447,0000.02%
WOLVERINE ASSET MANAGEMENT LLC 5,870$1,018,0000.02%
SIGNET FINANCIAL MANAGEMENT, LLC 44,675$77,0000.02%
SVB WEALTH LLC 195,000$335,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 288,900$497,0000.01%
J.P. Turner & Co Capital Mnagement, LLC 153,900$8,0000.01%
BALYASNY ASSET MANAGEMENT L.P. 640,400$1,101,0000.01%
View complete list of IMMUNOMEDICS INC shareholders